Welcome to our dedicated page for Delek US Holdings SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Delek US Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Delek US Holdings's regulatory disclosures and financial reporting.
Delek US Holdings, Inc. (DK) director Vasiliki (Vicky) Sutil filed a Rule 144 notice for a planned sale of common stock. The filing lists a proposed sale of 6,397 common shares of Delek US Holdings, Inc. through Fidelity Brokerage Services LLC, with an approximate aggregate market value of $457,385.50 and trading on the NYSE.
The notice also details how these shares were originally acquired as restricted stock vesting compensation from Delek US Holdings, Inc. between March 2023 and March 2024. Delek US Holdings, Inc. reports 61,232,174 common shares outstanding, which is a baseline figure, not the amount being sold.
Delek US Holdings, Inc. (DK) reported that executive vice president for special projects Reuven Spiegel sold a total of 7,500 shares of common stock on September 1, 2026 in open-market or private transactions, at prices around the low $73 range per share. No Rule 10b5-1 trading plan is reported for these sales.
Delek US Holdings, Inc. (DK) is the issuer of common stock that officer Reuven Spiegel plans to sell under Rule 144. The notice covers a proposed sale of 7,500 shares of Delek common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $549,096.80, to be sold on or after September 1, 2026 on the NYSE.
The filing also notes restricted stock vesting from the issuer that will provide 4,516 shares on February 27, 2026 and 2,984 shares on June 10, 2026 as compensation. In the past three months, Spiegel sold 10,000 shares of Delek common stock for $682,100.00.
Delek US Holdings, Inc. (DK) is the issuer of common stock covered by a notice of proposed sale filed for the account of director Richard J. Marcogliese. The notice covers a proposed sale of 2,000 shares of Delek US common stock through UBS Financial Services on the NYSE, with an aggregate market value of $142,100.00 based on the referenced price. The filing states that Delek US had 61,232,174 shares outstanding of common stock and lists an approximate sale date of August 21, 2026.
Delek US Holdings, Inc. (DK) director Gary M. Sullivan Jr. reported selling 27,688 shares of common stock on August 24, 2026. The sale was in the open market at a weighted average price of about $69.01 per share, with individual trade prices ranging from $69.00 to $69.15. After these transactions, he directly holds 32,004 shares of Delek US common stock.
Delek US Holdings, Inc. (DK) director Richard J. Marcogliese reported a sale of 2,000 shares of common stock on 2026-08-21 at $71.05 per share. The shares were held indirectly through the Marcogliese Family Revocable Trust, where he and his spouse are co-trustees and beneficiaries. After this transaction, the trust held 12,880 indirect shares, and he also reported 40,883 shares held directly.
Delek US Holdings, Inc. (DK) director William J. Finnerty reported a sale of 1,457 shares of Common Stock on 2026-08-21 in an open market or private transaction at $64.70 per share. After this transaction, he directly holds 33,348 shares of Delek US Holdings, Inc. Common Stock.
Delek US Holdings, Inc. (symbol DK) received a Rule 144 notice from director Gary M. Sullivan Jr., for whose account up to 27,688 shares of common stock held at Fidelity Brokerage Services LLC may be sold. The filing lists these shares as having an aggregate market value of $1,910,832.64, with 61,232,174 shares of common stock outstanding and a proposed sale date of August 24, 2026 on the NYSE. The shares derive from multiple restricted stock vesting awards granted as compensation between March 2018 and June 2025.
Delek US Holdings, Inc. (DK) has a notice of proposed sale of company stock under Rule 144 filed on behalf of director William J. Finnerty. The filing covers 1,457 shares of common stock held at Fidelity Brokerage Services LLC, with an indicated aggregate value of $94,267.90, and lists the NYSE as the trading market.
The shares to be sold trace to restricted stock vesting on June 10, 2025 from the issuer as compensation. The notice also reports that during the past three months, Finnerty sold 5,000 shares of Delek US Holdings common stock for total proceeds of $239,100.00. The form is signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for William Finnerty.
Delek US Holdings, Inc. (DK) reported that executive vice president, Special Projects, Reuven Spiegel filed a Form 4 for one open-market sale of 10,000 shares of common stock on August 18, 2026 at $68.21 per share. After this transaction, he directly holds 36,435 shares. The sale was made pursuant to a Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).